Low T Lawsuits: The Drugs Vs. The Risks

September 25, 2015 – – Banville Law reports that across the nation, millions of men are taking prescription low testosterone therapy drugs to battle the aging process. They are hopeful that these drugs will reduce their fatigue, increase their libido, and make them feel younger once again. A controversial question has arisen in the last few years, however, concerning whether these hormone therapies are actually harming rather than helping their patients.

The debate over low testosterone drugs now involves over 2,500 men from around the U.S., and it will soon be more highly exposed to the public eye, when bellwether trials begin in a Chicago courtroom, overseen by the Honorable Judge Matthew F. Kennelly. The cases, which were consolidated into a multidistrict litigation, will begin by addressing AndroGel, the most popular of the many testosterone treatments.

Men naturally experience lowered testosterone levels as they age, and these lowering hormone levels can produce some unpleasant side effects. Many of these men see advertising for testosterone therapies and are drawn to ask for prescriptions. Although the drugs were approved by the FDA to treat hypogonadism and similar, specific, diagnosed conditions, they are also being prescribed by doctors to treat these general symptoms of aging which have now been termed as “low t” conditions.

For many of the men who are now a part of the pending litigation against these low t drugs, the promise was too good to be true. They have experienced a range of serious health complications after using the treatments, from blood clots, to strokes, heart attacks, and even death. Several testosterone studies also linked these side effects to the medications, causing the FDA to indicate they will be further exploring the issue.

Tests regarding the drugs are ongoing. Dr. Mark Molitch, an endocrinologist at Northwestern Medicine is currently participating in a national study on the low t drugs, with results anticipated soon. This will only serve to further increase debates in court, where lawsuits include many of the product’s manufacturers.

Through pretrial discovery motions and talks with company officials, attorneys are hopeful to learn more about how the information on the products’ warning labels and in the products’ advertising campaigns were considered. Many plaintiffs allege that the information provided on warning labels was not thorough enough and did not indicate the dangers associated with the medication properly. Additionally, they claim that advertising was aggressive and designed to play the general public’s desire to remain as youthful as possible rather than aging.

As litigation progresses, others will likely join. The FDA recently made statements warning men about using low testosterone products for natural, age-related causes and also required the manufacturers to include information regarding heart attack, stroke, and blood clot risks on their labels.

If you would like further information on this topic or are interested in exploring your rights to sue after experiencing an adverse effect from taking a low testosterone therapy drug, contact Laurence Banville, Esq. of Banville Law. Laurence is currently reviewing cases for those involved and also sponsors the website LowTestosteroneCase.com, designed to provide pertinent information to anyone needing it.

To speak with Laurence Banville, Esq. directly, please call 917-809-6595 anytime.

###

Contact Banville Law:

Laurence Banville, Esq.
888-478-9711
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60004397